<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00140842</url>
  </required_header>
  <id_info>
    <org_study_id>2004-P-002191</org_study_id>
    <nct_id>NCT00140842</nct_id>
  </id_info>
  <brief_title>Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents</brief_title>
  <official_title>Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine hormonal differences in ghrelin and growth hormone in obese and
      normal weight adolescents and their relationship to body composition and insulin resistance.
      The study will also investigate the effect of the macronutrient composition of a meal on
      postprandial ghrelin levels and whether ghrelin responses will predict the degree of hunger
      and caloric intake at a subsequent meal.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity is an epidemic that is striking people at younger ages than ever before. Obesity is
      associated with changes in the secretory patterns of several hormones including ghrelin,
      growth hormone (GH), and insulin, which have not been examined in the adolescent age group.
      Ghrelin, a primarily gastric hormone, increases appetite and is a GH secretagogue. This study
      will compare the alteration in secretion of ghrelin and GH in overweight and normal weight
      adolescent girls through frequent blood sampling and GH stimulation testing with growth
      hormone releasing hormone and arginine. The relationship between these hormones and insulin
      resistance, measured by 1H-nuclear magnetic resonance spectroscopy, and body composition,
      measured by dual energy x-ray absorptiometry and magnetic resonance imaging, will be
      investigated. This study will also determine the postprandial ghrelin response to test meals
      that vary by the type of predominant macronutrient, which may predict the degree of hunger
      and amount of intake at a subsequent meal. Understanding obesity-related changes in ghrelin
      and GH and their relationship to body composition, insulin resistance, and appetite will help
      in the development of strategies to reduce complications of obesity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2005</start_date>
  <completion_date type="Actual">June 2007</completion_date>
  <primary_completion_date type="Actual">June 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Peak Growth Hormone (GH) on the GH Stimulation Test</measure>
    <time_frame>Baseline</time_frame>
    <description>Peak growth hormone (GH) on the GH stimulation test is a measure of the adequacy of GH secretion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visceral Adipose Tissue</measure>
    <time_frame>Baseline</time_frame>
    <description>Visceral adipose tissue was measured using magnetic resonance imaging at the level of the fourth lumbar vertebra (L4)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">47</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Obese girls</arm_group_label>
    <description>The inclusion criteria will be girls 12-18 years of age. According to the Centers for Disease Control and Prevention, the definition of obesity is a BMI higher than the 95th percentile for age and sex, and that of overweight is a BMI between the 85th and 95th percentiles. Cases will be defined as having a body mass index (BMI) greater than the 95th percentile for age according to the 2000 Centers for Disease Control and Prevention growth charts.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal-weight girls</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and urine collected
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Obese and normal-weight girls between 12-18 years old
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Girls 12-18 years of age

          2. Obese subjects: BMI higher than the 95th percentile for age and sex

          3. Normal-weight controls: BMI from the 15th to the 85th percentiles for age and sex

        Exclusion Criteria:

          1. History of disorders other than obesity that may affect growth hormone, ghrelin,
             cortisol, or insulin secretion such as eating disorder, diabetes mellitus,
             hypertension, thyroid disease, Cushing's syndrome, liver disease, renal failure, or an
             excess or deficiency of GH or cortisol

          2. Medications that could affect glucose and lipid levels or the secretion of growth
             hormone, ghrelin, insulin, or cortisol such as rhGH, glucocorticoids, and birth
             control pills

          3. Pregnancy

          4. Smoking or substance abuse

          5. Active dieting

          6. Surgical procedures for obesity

          7. Dietary restrictions such as bread, dairy, peanut, aspartame, or meat products used in
             the study

          8. Metal implants, including intracranial surgical clips or pacemakers
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Klibanski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Misra M, Tsai PM, Mendes N, Miller KK, Klibanski A. Increased carbohydrate induced ghrelin secretion in obese vs. normal-weight adolescent girls. Obesity (Silver Spring). 2009 Sep;17(9):1689-95. doi: 10.1038/oby.2009.86. Epub 2009 Mar 26.</citation>
    <PMID>19325538</PMID>
  </results_reference>
  <results_reference>
    <citation>Misra M, Bredella MA, Tsai P, Mendes N, Miller KK, Klibanski A. Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E385-92. doi: 10.1152/ajpendo.00052.2008. Epub 2008 Jun 10.</citation>
    <PMID>18544645</PMID>
  </results_reference>
  <results_reference>
    <citation>Russell M, Bredella M, Tsai P, Mendes N, Miller KK, Klibanski A, Misra M. Relative growth hormone deficiency and cortisol excess are associated with increased cardiovascular risk markers in obese adolescent girls. J Clin Endocrinol Metab. 2009 Aug;94(8):2864-71. doi: 10.1210/jc.2009-0380. Epub 2009 May 12.</citation>
    <PMID>19435823</PMID>
  </results_reference>
  <results_reference>
    <citation>Russell M, Mendes N, Miller KK, Rosen CJ, Lee H, Klibanski A, Misra M. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab. 2010 Mar;95(3):1247-55. doi: 10.1210/jc.2009-1475. Epub 2010 Jan 15.</citation>
    <PMID>20080853</PMID>
  </results_reference>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2005</study_first_submitted>
  <study_first_submitted_qc>August 30, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2005</study_first_posted>
  <results_first_submitted>March 3, 2011</results_first_submitted>
  <results_first_submitted_qc>August 2, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 2, 2011</results_first_posted>
  <last_update_submitted>October 3, 2011</last_update_submitted>
  <last_update_submitted_qc>October 3, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Anne Klibanski, MD</investigator_full_name>
    <investigator_title>Laurie Carrol Guthart Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Obesity, adolescent, ghrelin, growth hormone, cortisol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>17 obese and 30 normal-weight adolescents (12–18 yr old) were screened for study eligibility.15 obese adolescents completed the study visit. These subjects were matched for race, ethnicity, and bone age to normal-weight adolescents from the pool of screened subjects.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Normal-weight Girls</title>
          <description>Normal weight girls 12-18 years old</description>
        </group>
        <group group_id="P2">
          <title>Obese Girls</title>
          <description>Obese adolescents between 12–18 years old.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Normal-weight Girls</title>
          <description>Normal-weight girls were required to have a BMI between the 15th-85th percentiles</description>
        </group>
        <group group_id="B2">
          <title>Obese Girls</title>
          <description>Obese girls were required to have a BMI above the 95th percentile</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.9" spread="1.7"/>
                    <measurement group_id="B2" value="14.0" spread="1.9"/>
                    <measurement group_id="B3" value="14.9" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Peak Growth Hormone (GH) on the GH Stimulation Test</title>
        <description>Peak growth hormone (GH) on the GH stimulation test is a measure of the adequacy of GH secretion.</description>
        <time_frame>Baseline</time_frame>
        <population>This was a cross-sectional study to compare differences in growth hormone (GH) secretory status in relation to body composition in obese versus normal-weight girls. This was a pilot study and the analysis was performed using a Student t-test to compare means across groups</population>
        <group_list>
          <group group_id="O1">
            <title>Normal-weight Girls</title>
            <description>Normal-weight girls were required to have a BMI between the 15th-85th percentiles</description>
          </group>
          <group group_id="O2">
            <title>Obese Girls</title>
            <description>Obese girls were required to have a BMI above the 95th percentile</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Growth Hormone (GH) on the GH Stimulation Test</title>
          <description>Peak growth hormone (GH) on the GH stimulation test is a measure of the adequacy of GH secretion.</description>
          <population>This was a cross-sectional study to compare differences in growth hormone (GH) secretory status in relation to body composition in obese versus normal-weight girls. This was a pilot study and the analysis was performed using a Student t-test to compare means across groups</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.1" spread="16.1" lower_limit="0" upper_limit="100"/>
                    <measurement group_id="O2" value="25.2" spread="21.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis was that there is no difference between the groups for peak growth hormone on the growth hormone stimulation test.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>15</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>16</dispersion_value>
            <ci_percent>95</ci_percent>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visceral Adipose Tissue</title>
        <description>Visceral adipose tissue was measured using magnetic resonance imaging at the level of the fourth lumbar vertebra (L4)</description>
        <time_frame>Baseline</time_frame>
        <population>The analysis was completed on the 30 participants as per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Normal-weight Girls</title>
            <description>Normal-weight girls were required to have a BMI between the 15th-85th percentiles</description>
          </group>
          <group group_id="O2">
            <title>Obese Girls</title>
            <description>Obese girls were required to have a BMI above the 95th percentile</description>
          </group>
        </group_list>
        <measure>
          <title>Visceral Adipose Tissue</title>
          <description>Visceral adipose tissue was measured using magnetic resonance imaging at the level of the fourth lumbar vertebra (L4)</description>
          <population>The analysis was completed on the 30 participants as per protocol</population>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" spread="7.5" lower_limit="0" upper_limit="100"/>
                    <measurement group_id="O2" value="42.7" spread="17.0" lower_limit="0" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis is that there is no difference between the groups for visceral adipose tissue</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>23.7</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>12</dispersion_value>
            <ci_percent>95</ci_percent>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Normal-weight Girls</title>
          <description>Normal-weight girls were required to have a BMI between the 15th-85th percentiles</description>
        </group>
        <group group_id="E2">
          <title>Obese Girls</title>
          <description>Obese girls were required to have a BMI above the 95th percentile</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Limited number of participants-pilot study</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Madhu Misra, MD</name_or_title>
      <organization>Massachusetts General Hospital</organization>
      <phone>617-724-5602</phone>
      <email>mmisra@partners.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

